Generative AI in MedTech: Proven Practices for Regulated Teams
Experienced device manufacturers no longer need another list of imaginative prompts. They need a defensible operating model for Generative AI in MedTech: one that produces measurable gains in design, regulatory, clinical, and quality workflows while surviving validation review, internal audit, cybersecurity scrutiny, and model change. The decisive work happens after a promising prototype. Teams must define where generated content may enter a controlled process, how evidence follows each output, who is accountable for acceptance, and what happens when system behavior drifts. Those details separate an interesting assistant from a capability that can be trusted across a global product portfolio. The practical case for Generative AI in MedTech is strongest where specialists repeatedly reconcile large volumes of heterogeneous evidence. A design assurance lead may need to connect changed user needs with risk controls and verification results. A regulatory writer may compare claims against c...